abstract Hypoglycemia is not an independent diagnosis. it is a pathophysiological syndrome whose cause needs to be identified. Identifying it is just the first step to making the diagnosis as precisely as possible and to preventing brain damage. timely diagnosis and treatment are factors of paramount importance for the prognosis of affected patients. the aim of this study was to present two of our patients with hyperinsulinemic hypoglycemia because of the rarity of the condition and to propose a diagnostic-therapeutic algorithm of hypoglycemic syndrome in childhood. Identifying the genetic mutations using DNA analysis for both children enabled us to determine the prognosis and to provide genetic counseling about the next pregnancies in the affected families. We make a detailed classification of different types of hypoglycemia and the various therapeutic modalities: dietary, medicinal and surgical depending on the etiology. it is concluded that the highly specialized examinations which ensure the etiological diagnose, treatment, prognosis and genetic consultation demand the participation of a well trained medical team -both in the clinical division and in the laboratory.
Glucose homeostasis is critical for the realization of brain metabolism; insufficient supply of glucose may cause seizures, irreversible brain damage and even death. In infants the percentage of the brain in relation to the other parts of the body is relatively greater than that in adult individuals. That is why glucose requirements of infant's brain are relatively greater than those of adult's brain (6-8 mg/kg/min for infants and 2 mg/kg/min for adults). The brain of the newborn and the infant enlarges and develops rapidly which makes it extremely sensitive to hypoglycemia. Lack of good adaptation to starvation is the most common reason for hypoglycemia in children. The adaptation mechanisms of homeostasis during starvation are: 1. glycogenolysis, 2. gluconeosynthesis, 3. lipolysis and 4. fatty acid oxidation and ketogenesis (Fig. 1) . 1 Each of these mechanisms is strictly regulated by hormones. Insulin suppresses adaptation to hypoglycemic conditions, while counterinsular hormones such as glucagon, growth hormone, cortisol and epinephrine improve it.
Hyperinsulinism is the most frequent cause of persistent hypoglycemia in infancy. An estimated incidence of hyperinsulinemic hypoglycemia (HH) is 1 in 30 000-50 000 live births. It first appears most often in the neonatal period and in infancy. Its clinical presentation is: high weight at birth, plethoric facies, enlarged internal organs, muscular hypotonia, hypothermia, seizures or loss of consciousness. Later in life the symptoms of hyperinsulinemic hypoglycemia vary -hunger, sleepiness, excessive sweating, confusion, behavioural changes, seizures. No matter what the cause is, hypoglycemia should be identified and treated immediately because of the risk of irreparable brain damage if it persists. Further examinations aim to determine the etiology of hyperinsulinemic hypoglycemia which is a guarantee for an adequate approach -concerning treatment (surgical or medicinal), nutrition (the necessity of a specific diet), prognosis (transient or permanent) and heredity with possible risks of involving other children of the family too. [1] [2] [3] proved to have mutations of АВСС8 gene, which codes for SUR 1 subunit of the АТР-depending К-channels. According to Robert S. Gillespie et al. the incidence of hyperinsulinemic hypoglycemia worldwide is 1 in 25 000 newborns. 1 The aim of our study was to present two cases with the extremely rare disorder of hyperinsulinemic hypoglycemia in infancy and the difficulties we had in their diagnosing, genetic specification and treatment, as well as to propose a diagnostic and therapeutic algorithm for the treatment of this rare pathological condition. [4] [5] [6] [7] [8] 
DiagnostiC algorithm of hypoglyCemia
History: family, time of onset and relation to nutrition: -early postprandial hypoglycemia -a defect of glycogenolysis or hyperinsulinism -late hypoglycemia -after continuous fastingdisturbances of fat metabolism, glyconeogenesis and of the hormones which control it -cortisol and epinephrine.
Status: overweight, growth retardation, hepatomegalia, hypogenitalism. The symptoms associated with hypoglycemia may develop in two phases: first phase -associated with the sympathoadrenal system and increased secretion of catecholamines and neurotransmitters, and second phase -neurohypoglycemia which causes brain hypoxia and edema. 2 Laboratory studies: blood glucose, blood gas analysis, insulin, C-peptide, cortisol, ACTH, growth hormone, ТTН, thyroxin, free fatty acids, β-hydroxybutirate, lactate, ammonium, carnitine. Tests -oral glucose tolerance test (GTT), glucagon test. Urine -ketones, organic acids, non-glucose reducing substances. Figure 2 presents a diagnostic-therapeutic algorithm applicable for everyday practice. 9 When genetically dependent hyperinsulinemic hypoglycemia is suspected it is possible to carry out additional genetic examination of the child and its family. KCNJ11, GLUD-1, GCK, HADH, MPI, HNF4A with autosomal recessive or autosomal dominant heredity; sporadic cases were also reported. [11] [12] [13] ClassifiCation of hypoglyCemias І. Тransient neonatal hypoglycemia -it is caused by endogenous or exogenous substrate insufficiency and/or immature enzyme and endocrine function as well as by increased consumption. It appears in 10% of the mature newborns and more frequently in cases of prematurity, in infants who are too small for their gestational age, in children of diabetic mothers, in discordant twins and in cases of perinatal asphyxia. In such cases transient hyperinsulinemism is supposed secondary to the perinatal stress. ІІ. Persistent neonatal hypoglycemia, hypoglycemia in infancy and hypoglycemia of later age -it is most often determined by genetic defects of the insulin secretion, but all congenital metabolic and endocrine disorders are also included in this group. 1. Hyperinsulinism -it is the most common cause of hypoglycemia in the neonatal period and the second in frequency after ketogenic hypoglycemia in older children. 14 It is characterized by early manifestation -in 60% of the cases it occurs as early as in the first week of life. The clinical presentation is dominated by the neurological symptoms of hypoglycemia -seizures, lethargy, neuropsychological developmental delay. Laboratory constellation in all of these forms is associated with the high insulin levels > 2 µIU/ml, free fatty acids levels < 1.5 mmol/L, hypoketonemia -plasma-β-hydroxybutyrate < 2.0 mmol/L and positive glycemic response to the glucagon stimulation test -over 2.5-fold increase of the initial blood glucose levels, which indicates good hepatic glycogen reserves and glycogenolysis enzymes. The introduction of the genetic tests has made it possible to identify several forms of hyperinsulinism with different course, treatment, inheritance and prognosis: А. Congenital hyperinsulinism as a result of K ATP /SUR1 and KIR6.2/ -channel mutations. 15 Gene locus -11р15.1, diffuse forms of recessive or dominant inheritance, АВСС8 gene which codes for SUR1 and KCNJ11 gene which codes for KIR6.2. These are the most frequent forms of congenital hyperinsulinism but there are more than 100 mutations of АВСС8 gene and 20 of KCNJ11 gene which are also well known. SUR1 subunit is sensitive to changes of β-cells energetic status; it regulates the mechanisms of opening and closing of the potassium channel pores. The forms of recessive inheritance have a heavier course. The constant open state of the K ATP channels results in disturbances of β-cell function regarding the decrease of insulin secretion in hypoglycemia. Hyperinsulinism in this genetic variant is additionally enhanced by the intake of amino acids with food because they have a depolarization effect on the cell membrane. The frequency of this condition is about 1 in 40 000 newborns, but in a country with high rates of consanguinity such as Saudi Arabia the reported frequency is 1/3000. 3 The focal form is associated with a mutation of the paternal K ATP channel and with a specific loss of maternal allele and imprinting of 11р15 chromosome locus. The loss of the normal tumor-suppressing gene of the maternal allele leads to focal expansion of abnormal β-cells and to the development of focal pancreatic lesions. 1 B. Congenital hyperinsulinism as a result of gene GLUD-1 mutation, which codes for the mitochondrial enzyme glutamate-dehydrogenase. In it hypoglycemia is combined with hyperammonemia. C. Glucokinase hyperinsulinism -glucokinase catalyses glucose phosphorilation which is the first step of glycolysis.
D. Congenital hyperinsulinism associated with SCHAD-deficiency.
It is an autosomal-recessive hereditary disorder which is associated with a defect of the enzyme activity of SCHAD (short chain 3-hydroxyacyl-CoA-dehydrogenase) -a mitochondrial enzyme which catalyses the conversion of 3-hydroxyacyl CоА into 3-ketoacyl CоА -the third step of the β-oxidation cycle of the fatty acids. E. Congenital hyperinsulinism associated with carbohydrate-deficient glycoprotein syndrome type 1В. Carbohydrate-deficient glycoprotein syndromes present a heterogeneous group of disorders which are characterized by psychomotor and mental retardation, coagulation disturbances and glycoprotein hypoglycolyzation. Type 1B is characterized by hyperinsulinemic hypoglycemia, sometimes by protein-losing enteropathy and congenital hepatic fibrosis, but it does not affect neuropsychological development. Genetically, it is connected with mutation of phosphomannose isomerase, but for the present moment there is no explanation of the hyperinsulinemic hypoglycemia. Clinically it present with protein-losing enteropathy and hypoglycemic conditions. F. Hyperinsulinemic hypoglycemia in children with diabetic mothers. Hyperglycemia in utero to which the fetus of poorly compensated diabetic mother is subjected results in compensatory hyperinsulinemia and macrosomia. 
Disorders of gluconeogenesis
А. Galactosemia -this is a genetic autosomal recessive disorder which is a result of defects of three main enzymes, as in the most frequent classic form it is connected with deficiency of galactose-1-phosphate-uridyltransferase. B. Hereditary fructose intolerance -it is an autosomal recessive disorder in which fructose-1-phosphate accumulates in the liver, kidneys and the intestine as a result of fructose-1-phosphate-aldolase deficiency. C. Disorders of fatty acid oxidation -various enzyme defects are known which affect the α-oxidative cycle, the synthesis of ketones, the carnitine cycle and the mitochondrial transfer. Β-oxidation of fatty acids is closely associated with the generation of energy for gluconeogenesis and because of that hypoglycemia is the main symptom. The most common defects are deficiency of medium-chain acetyl-CоА-dehydrogenase and carnitine deficiency. They cause hypoketogenic hypoglycemia at the age between 6 and 24 months at continuous fasting, vomiting and infections which often cause encephalopathy and death.
D. Disorders of amino acid and organic acid metabolism
-Maple syrup urine disease -Leucinosis -Tyrosinosis -Propionic acidemia -Methylmalonic acidemia -Hydroxy-3-methylglutaryl acidemia.
The diagnosis in such cases is proved by metabolic screening. Prenatal diagnosing is also possible. 1 5. Hypoglycemias in substrate deficiency А. Ketogenic hypoglycemia -it is the most common cause of hypoglycemia in older children. Usually it occurs after continuous fasting or is associated with different infections. B. Hypoglycemias in:
-malnutrition -malabsorption -diarrhea -burns -shock -Munchhausen syndrome 6. Hypoglycemias in hepatic and systemic disorders -Reye's syndrome -Hepatitis -Cirrhosis -Sepsis -Heart failure -Renal failure etc. 7. Drug-induced hypoglycemia -insulin, calculates, ethyl alcohol, oral anti-diabetic drugs etc. 8. Defects of glucose transporters -GLUT 1 and GLUT 2 deficiency -they induce hypoglicorrachia at normal plasma levels of glucose. [1] [2] [3] 8 conclusions Hypoglycemias in neonatal period and infancy are comparatively frequent and need immediate diagnose and treatment. Rarer even is the condition of hyperinsulinemic hypoglycemia, which needs exact biochemical, hormonal, imaging and genetic diagnosing. Over the last decades, thanks to the highly improved laboratory methods a number of disorders have been found other than insulinoma, which was described by Gerhard Katsch 70 years ago. Highly specialized examinations which ensure the etiological diagnosis, treatment, prognosis and genetic consultation require participation of a well trained medical team -both in the clinical divisions and in the laboratories. Modern pharmacology has made treatable a number of diseases with fatal outcomes in the near past. The two cases presented by us are of casuistic interest because of their rarity as disorders and because of our success to diagnose the extremely rare double hemizygosity of Folia Medica 2010; 52(3): 62-69 © 2010 Medical University Plovdiv the pathologic genes in the first case. The favourable effect of the medical treatment with diazosid and somatostatin and with an adequate diet which resulted in improved blood glucose levels also illustrates the accuracy of the diagnosis and supports literature data which was cited in the review. The practical diagnostic therapeutic algorithm presented by us may be suitable to help precise diagnosing without unnecessary examinations. A part of the diagnostic procedures which refer to the specific gene defect for the present moment are inaccessible in our country. 
